Few studies have addressed the involvement of FMRD6 protein in the immune response; it is thought to be a neoantigen directly associated with the expression of HLA-A, and B and T cell activation characteristic of immune activated basal-like breast cancers with favorable prognosis [50]. The gene discussed is HLA-A; the disease is breast carcinoma.